PEMAZYRE cpr 13.5 mg 14 pce
7680681430056
CH-68143
L01EN02
07.16.1.
Active substances:
1 / 3
google
Details
- Product number
- 6814303
- CPT
- -
- Packaging group
- 14
- Unit
- Tablette(n)
- Composition
- pemigatinibum 13.5 mg, cellulosum microcristallinum, carboxymethylamylum natricum A corresp. natrium 0.528 mg, magnesii stearas, pro compresso.
Articles (1)
Pemazyre 13,5 mg, comprimés
Tabletten
14
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
pemigatinibum
|
13.5 MG | Substance | Wirkstoff (Principe actif) |
|
cellulosum microcristallinum
|
- | Substance | HNIDK |
|
carboxymethylamylum natricum
|
- | Substance | HNIDK |
|
natrium
|
0.528 MG | Substance | HBESI |
|
magnesii stearas
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 7124.60
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/11/2022
Authorization holder
Incyte Biosciences International
1110 Morges
Authorization information
- Swissmedic authorization number
- 68143
- Drug name
- Pemazyre, comprimés
- Galenic form
- TAB
- ATC Code
- L01EN02
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 13/07/2021
- Authorization expiration date
- 23/07/2030
- IT number
- 07.16.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- PEMAZYRE cpr 13.5 mg 14 pce
- Description (DE)
- PEMAZYRE Tabl 13.5 mg 14 Stk
- Market launch
- 13/07/2021
- Narcotic (BTM)
- No